Synthesis and Antimicrobial Screening of Metal-ligand Complexes Derivative from (2-chloroquinolin-3-yl)methylene)hydrazine) and their Biological Studies


Sangeeta S. Badade1, Dattatraya N. Pansare1, Rohini N. Shelke2, Priyanka Kashid1and Saroj R. Bembalkar1*

1Department of Chemistry, Deogiri College, Chhatrapati Sambhajinagar, MS, India

2Department of Chemistry, Radhabai Kale Mahila Mahavidyalaya Ahmednagar, MS, India.

Corresponding Author E-mail: s_bembalkar@yahoo.com

DOI : http://dx.doi.org/10.13005/ojc/410305

Download this article as:  PDF

ABSTRACT:

This study presents the synthesis of a Schiff base ligand, 1,2-bis((2-chloroquinolin-3-yl)methylene)hydrazine, via a condensation reaction between an amine and a carbonyl compound. The resulting ligand was subsequently utilized to synthesize Cu(II), Co(II), and Ni(II) complexes. Characterization of the ligand was performed using analytical techniques such as ¹H NMR, FTIR, and mass spectrometry. Further structural analysis of the metal complexes was conducted through spectroscopic methods, including FTIR and UV. Their antifungal activity was assessed in vitro, revealing that the Ni(II) complex exhibited the highest efficacy against the tested fungal strains. Additionally, the Zn(II) complex demonstrated notable antifungal properties, with activity ranging from 14–35 µg/mL against Candida albicans, Candida glabrata, Aspergillus flavus, and Cryptococcus neoformans. The antibacterial potential of the complexes was also evaluated in vitro against three distinct bacterial strains. Compounds 6b and 6h displayed comparable potency to the reference drug Ampicillin against Escherichia coli, with IC50 values of 46 µg/mL. Furthermore, compound 6h exhibited similar activity to Ampicillin against Bacillus subtilis, with an IC50 value of 50 µg/mL.

KEYWORDS:

Antibacterial; Antifungal activity; Bis hydrazine; Metal complexes

Introduction

The chemistry of transition metal complexes has garnered significant interest due to their catalytic and bioinorganic properties. These complexes are also noteworthy for their potential biological activities, including anticancer1, antimicrobial2, antimalarial3, and antitumor4. antibacterial5, antiviral6, antinflammatory7, antioxidant8. Schiff base compounds, which are formed through thecompression of prime amines by carbonyl compounds (aldehydes) and the elimination of water molecules, are particularly important in this context. The formation of Schiff bases is often facilitated by the presence of a dehydrating agent (Scheme 1).

The choice of metal integrated into the complex and the particular Schiff base utilized have a substantial impression on their biological activity. Metal-Schiff base compounds demonstrate more potent drug action mechanisms than their decently organic counterparts. Owing to the biologically active azomethine group, Schiff bases serve as highly effective ligands for metal compounds. This azomethine structure, with its electron-deficient carbon and electron-rich nitrogen, facilitates diverse electrophilic and nucleophilic reactions at these specific sites9-11.

Schiff bases that coordinate with oxygen, nitrogen, and other similar donor atoms, and their complexes, have been extensively studied and statedto exhibit a comprehensivevarietyof biological activities, with activity beside bacteria, fungi, and certain types of tumors. These compounds possess numerous biochemical, clinical, and pharmacological properties12. The synthesis of the metal complexes followed procedures reported in the literature13,14.

The chemistry of Schiff bases represents a significant area of study within coordination chemistrybecause of their capacity to form stable multiplexes with various metal ions, leading to applications across multiple disciplines. A notable focus in this field has been theusageofSchiff-base ligands to progressphenoxo-bridged binuclearmultiplexesby eitherhomometalliccenters. These Schiff-base complexes are crucial in biomedical, biomimetic, and catalyticorganizationsand also support liquid crystalline phases15-22. Schiff bases synthesized from aliphatic aldehydes tend to be more unstable and prone to polymerization compared to those derived from aromatic aldehydes, which exhibit greater stability due to more effective conjugation. Aldehydes, which are less sterically hindered and more electrophilic than ketones, react more readily, facilitating the formation of Schiff bases. The simplicity of synthesis and the ready availability of Schiff bases have made them a subject of considerable interest. The development of several applications in the fields of inorganic23, bioinorganic24, organic synthesis25, environmental26, and coordination chemistry27 are the significant interest. 

Materials and Methods

All the procured substances used were methodical mark, distilled solvents were used.

Metal salts were used without further refinement. 

Scheme 1: Synthesis of hydrazine derivative.Click here to View Scheme

In 50 ml round bottom flask to stirred solution of compound (1) (1mmol) in ethanol (10 mL) was treated by hydrazine hydrate (2) (6 mmol) and 1-2 drops of rigorous sulphuric acid at room temperature. The reaction mixture was refluxed in a preheated oil bath for four hours, resulting in the formation of 2-chloro-3-(hydrazonomethyl)quinolone (3). Subsequently, an extra 1 mmol of 2-chloroquinolin-3-carbaldehyde (4) and 1–2 drops of concentrated H₂SO₄ were introduced, and the mixture was further refluxed for another four hours. Upon conclusion of the reaction, as observed by T. L.C. by means of an ethyl acetate: n-hexane (3:7) system, the solvent was evaporated. The resulting crude product was precipitated by adding ice, followed by filtration, drying, and recrystallization from ethanol.The isolated yellow solid was confirmed by NMR and Mass spectroscopic analysis. IR (KBrcm-1): 3402 (OH), 3011 (Ar-H), 1668 (Imine C=N), 1579 (C=C), 1170 (C-O-C).

Preparation procedure

Scheme 2: Preparation procedureClick here to View Scheme

The metal salts (1mmol) were addition the ethyl alcohol solution of the ligand (5) (2 mmol). A some what basic pH of the reaction was carried out in slightly basic condition by adding 1 mmol of ammonia, and then this contentswere refluxedup to 5 to 6 hrs. The development of the reaction was checked by using T.L.C. and also monitored the colour changes. The subsequent yield was poured on petri dish and cool, filtration and dehydrated (6a-h). Each product was recrystallized from ethanol andthen take out its melting point, confirmed by IR and UV spectroscopy. Physical data of synthesized compounds are shows in table 1.

Table 1: Physical information of manufactured complexes 

Entry Sample code Ligand/metal salt Elemental analysis (%)
C H N M Cl
1 5 Ligand 63.32 3.17 14.77 0 18.73
2 6a CdL4 55.14 2.76 12.87 12.91 16.31
3 6b CoL4 58.75 2.94 13.71 7.21 17.38
4 6c CuL4 58.43 2.92 13.63 7.73 17.28
5 6d NiL4 58.77 2.93 13.71 7.18 17.39
6 6e FeL4 58.98 2.94 13.76 6.86 17.45
7 6f SrL4 56.76 2.83 13.24 10.36 16.79
8 6g ZnL4 58.29 2.91 13.60 7.94 17.24
9 6h ZrL4 56.52 2.82 13.19 10.74 16.72

Spectroscopic data of Synthesized metal Complexes

The N-H stretching band of the free ligand exhibited a shift towards lower frequencies in the spectra of all complexes, suggesting the involvement of the N-H group in complex formation. The infrared spectral data (ν, cm-1) for C=N, M-N, and C-H bonds in the metal complexes is provided.

The (6a) complex have Lemon yellow colour solid with melting point 274°C infrared Spectral values (cm-1) 1672 (C=N), 639 (M-N), 3068 (C-H), 3268 (O-H), UV spectra of the (6a) metal complex werenotedin ethanol solvents λmaxvalue is 344.99 nm.

(6b) Complex have grey colour solid with melting point >3000C Infrared Spectral values (cm-1) 1611 (C=N) 687(M-N), 3071(C-H), 3486 (O-H), UV Spectra of the (6b) metal complex were noted in ethanol solvents λmaxvalue is 201.58 nm.

(6c) Complex have yellowish brown colour solid with melting point 2800C Infrared Spectral values (cm-1)1611 (C=N), 687 (M-N), 3072 (C-H), 3407 (O-H), UV spectra of the (6c) metal complex were noted in ethanol solvents λmaxvalue is 385.53 nm.

(6d) Complex have brown colour solid with melting point 2980C Infrared Spectral values (cm-1)1580 (C=N), 689 (M-N), 3055 (C-H), 3180 (O-H), UV spectra of the (6d) metal complex were noted in ethanol solvents λmaxvalue is  nm.

(6e) Complex have yellow colour solid with melting point >3000C Infrared Spectral values (cm-1) 1581 (C=N), 646 (M-N), 3060 (C-H), 3133 (O-H), UV spectra of the (6e) metal complex were noted in ethanol solvents λmaxvalue is 383.28 nm.

(6f) Complex have white colour solid with melting point >3000C Infrared Spectral values 1610 (C=N), 688 (M-N), 3069 (C-H), 3389 (O-H), UV spectra of the (6f) metal complex were noted in ethanol solvents λmaxvalue is 350.06 nm.

(6g) Complex have yellowish green colour solid with melting point 2700C Infrared Spectral values cm-1611 (C=N), 689 (M-N), 3070 (C-H), 3497 (O-H), UV spectra of the (6g) metal complex were noted in ethanol solvents λmaxvalue is 203.6 nm.

(6h) Complex have lightYellow colour solid with melting point 2860C Infrared Spectral values 1596 (C=N), 686 (M-N) 3065 (C-H), 3429 cm-1 (O-H). UV spectra of the (6h) metal complex were noted in ethanol solvents λmaxvalue is 343.06 nm.

Result and Discussion

Antifungal activity (in vitro)

The newly manufacturedcomplexes were evaluated for theirin vitroAntifungal activity in contradiction ofnumerous fungal pathogens. MICstandards were resoluteby means of the normal agar technique, with Miconazolehelping as the reference drug. Dimethyl sulfoxide was used as the solvent control. TheMIC values (µg/mL) for the tested compounds and Miconazole are presented in Table 2. According to the data in Table 1, all synthesized compounds demonstrated decentto reasonableantifungalefficacy in contradiction of the examined fungal strains.

Table 2: Antifungal activity of complexes

Complexes MICa µg/mL
C.albicans C.glabrata A. fumigates A. flavus C.neoformans
6a 51 50 57 37 39
6b 25 28 38 15 16
6c 26 29 38 18 15
6d 28 32 44 20 20
6e 22 24 32 11 10
6f 30 32 41 22 25
6g 35 36 40 18 24
6h 25 24 35 14 14
Miconazole 25 25 35 12 12

a Values are theordinaryof threeevaluations

The results revealed that the entire Schiff base metal complex complexesexhibition antifungal activity. The compounds with the decent antifungal outlineswere 6b, 6e, and 6h, each awarding at slightestone MIC value reachingbetween10-40 µg mL-1. Table 1 results observations show that the Schiff base metal complex compounds are more active than their respective Schiff base. The Ni complex i.e. 6ewas found to be highly active towards all the selected fungi strains. A good effectiveness is exhibited by Zn complex i.e. 6h, which acts in the range 14–35 µg mL-1 toward C. albicans, C.glabrata, A. fumigates, A. flavusand Cryptococcus neoformans.

Antibacterial activity (in vitro)

The antibacterial properties of the newly manufacturedcomplexeswere assessed in vitro against three distinct bacterial strains. MIC standards were measured by means of the normal agar process, with Ampicillin serving as the reference drug and DMSO as the solvent control. The results, as shown in Table 3, indicate that the synthesized compounds exhibited moderate to strong antibacterial effects in contradiction ofE.  coli, B. subtilis, and S. aureus.

Table 3: Antibacterial activity (in vitro) data

Compounds MICa µg/mL
E.  coli B. subtilis S. aureus
6a >100 >100 >100
6b 46 48 48
6c 50 50 50
6d 56 60 52
6e 62 55 60
6f 70 70 72
6g 60 55 60
6h 48 50 52
Ampicillin 50 50 48

a Values are the ordinary of three evaluations

The consequences ofAntibacterial activity (in vitro) as obtainablein Table 3,indicate that the manufacturedcomplexes6b and 6hwereoriginateto beadditional equipotent to that oftypical drug Ampicillin against Escherichia coli IC50values 46 µg/mL and 48 µg/mL correspondingly. The synthesized complexes 6hwerefound to be equipotent to that of standard drug Ampicillin against Bacillus subtilis IC50value 50 µg/mL. It was also noticed that the derivatives with the “Zn” and “Cd” metal in their structure were found to be potent compounds among the other synthesized derivatives.

Conclusion

In conclusion, a new ligand was synthesized using aldehydes, vanillin and 2-chloro-3-carbaldehyde,along with amine hydrazine hydrate. This ligand was further utilized for the synthesis of metal-ligand complexes. The anewmanufactured ligand and metal complexes were categorizedby means of various spectroscopic methods, including 1H NMR, Mass spectrometry, IR spectroscopy, UV spectroscopy, and antibacterial and antifungal activity assays. The monodentate Schiff base substituted hydrazineLigand and its metal developments were positivelymanufactured and categorized using the aforementioned spectroscopic techniques. The antifungal and antibacterial activities of themanufactured metal complexes were evaluated, revealing that the compound Ni exhibited significantly good in vitroantifungal activity against C.albicans, C.glabrata, A.fumigatus, A.flavus, and C.neoformans. Complexes with Cd and Zn demonstrated in vitroantifungal activity when compared to the standard drug Miconazole against the fungiform strains C.albicansand C. glabrata.

Acknowledgement

The authors extend their heartfelt appreciation to the Principal and Head of the Chemistry Department, Deogiri College, ChhatrapatiSambhajinagar, Maharashtra, India, for generously providing access to the laboratory facilities essential for conducting this research. This article does not involve any studies conducted with human or animal participants by any of the authors.

Funding Sources

There is no any funding for this research

Conflict of Interest

We announced no conflicts of interests.

References

  1. Afrasiabi Z.; Sinn E.; Padhye S.; Dutta S.; Padhye S.; Newton C.; Anson C. E.; Powell A. K., Transition metal complexes of phenanthrenequinonethiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in vitro anticancer activity against human breast cancer cell-line, T47D. Journal of Inorganic Biochemistry., 2003, 95(4), 306-314.
    CrossRef
  2. Abd El-Halim, H.F.; Mohamed, G.G; Anwar, M.N., Antimicrobial and anticancer activities of Schiff base ligand and its transition metal mixed ligand complexes with heterocyclic base, Applied Organometallic Chemistry., 2018, 32:e3899
    CrossRef
  3. Aggarwal S.; Paliwal D.; Kaushik D.; Gupta GK.; Kumar A.,Pyrazole Schiff Base Hybrids as Anti-Malarial Agents: Synthesis, In Vitro Screening and Computational Study. Comb Chem High Throughput Screen.,2018, 21(3),194-203.
    CrossRef
  4. A.; Al-HakimiA.N.; El-Sayed SaeedS.; Alhamzi E.H.L.; Albadri A.E.A.E., Synthesis, characterization, and anticancer activity of some metal complexes with a new Schiff base ligand, Arabian Journal of Chemistry.,2022, 15 (2),103559.
    CrossRef
  5. Jarrahpour A.; Khalili D.; De Clercq E.; Salmi C.; Brunel J.M., Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives, Molecules., 2007, 12 (8), 1720–1730.
    CrossRef
  6. Sonmez F.; Gunesli Z.; Kurt B.Z.; Gazioglu I.; Avci D.; Kucukislamoglu M., Synthesis, antioxidant activity and SAR study of novel spiro-isatin-based Schiff bases, Molecular Diversity.,2019, 23 (4), 829–844.
    CrossRef
  7. Timofeeva D.S; Ofial A.R.; Mayr H., Nucleophilic reactivities of Schiff base derivatives of amino acids, Tetrahedron, 2019, 75, 459–463.
    CrossRef
  8. Xia M.; Wang S.H.; Yuan W.B., Lewis acid catalyzed electrophilic substitution of indole with aldehydes and Schiff bases under microwave solvent-free irradiation, Synthetic Communication., 2004, 34, 3175–3182.
    CrossRef
  9. Wantulok J.; Szala M.; Quinto A.; Nycz J.E.; Giannarelli S.; SokolovaR.; Ksiązek J. Kusz, M.,Synthesis, electrochemical and spectroscopic characterization of selected quinolinecarbaldehydes and their Schiff base derivatives, Molecules., 2020, 25 , 2053–2073.
    CrossRef
  10. ; PurohitS.; Oswal P.; Rawat S.; NegiV.; Singh A.K.; Kumar A.; Nucleophilic substitution reactions in the synthesis of selenium donor containing schiff bases: applications of metal complexes in homogeneous catalysis, New Journal of Chemistry., 2023, 47,12511–12535.
    CrossRef
  11. Isloor A. M.; KallurayaB; Shetty P.,European Journal of Medicinal Chemistry.,2009,44, 3784- 3787.
    CrossRef
  12. Obaleye J. A.; Akinreme C. A.; Balogun E. A.; Adebayo J. O., Toxicological studies   and antimicrobial properties  of  some  Iron  (III) complexes of  African Journal of Biotechnology., 2007,6:2826–2832.
    CrossRef
  13. Abd E. W.; El, S., Derivatives of phosphate Schiff based transition metal complexes: synthesis, studies and biological activity. SpectrochimicaActa., 2004, 60(1-2), 271–277.
    CrossRef
  14. Shiu K. B.; Liu S. A.; Lee G. H., One-pot conditional self-assembly of multicoppermetallacycles, Inorganic Chemistry.,2010, 49(21), 9902–9908.
    CrossRef
  15. Yeşilel O. Z.; Erer H.; Kaştaş G.; Kani I. B., Hydrogen bonded networks and a self-assembled 1D water cluster in nickel(II) and copper(II)-orotate complexes, Polyhedron,2010, 29(13), 2600–2608.
    CrossRef
  16. Habib H. A.; Gil-Hernández B.; Abu-Shandi K.; Sanchiz J.; Janiak C., Iron, copper and zinc ammonium-1-hydroxyalkylidene-diphosphonates with zero-, one- and two-dimensional covalent metal-ligand structures extended into three-dimensional supramolecular networks by charge-assisted hydrogen-bonding, Polyhedron., 2010, 29(12), 2537–2545.
    CrossRef
  17. Al-Jeboori M. J.; Al-Shihri A. S., An unusual coordination of potentially binucleating N2O Schiff base ligands with rhenium, Journal of Saudi Chemical Society.,2001, 5(3), 341-343.
  18. Al-Jeboori M. J.; Kashta A. A., Oxo-rhenium(V) complexes with tridentate Schiff base ligands, Mu’Tahlil-BuhuthWadirasat., 2004,19, 89-100.
  19. Costamagna J.; Ferraudi G.;Matsuhiro B.; Complexes of macrocycles with pendant arms as models for biological molecules, Coordination Chemistry Reviews., 2000, 196, 125–164.
    CrossRef
  20. Coughlin P. K.; Lippard, S. J.; Copper(II) chemistry in hexaazabinucleating macrocycles: hydroxide and acetate derivatives, Journal of the American Chemical Society., 1984,106(8), 2328–2336.
    CrossRef
  21. Januszko A.; Kaszynski P.; Grüner B., Liquid crystalline derivatives of bis(tricarbollide)Fe(II), Inorganic Chemistry., 2007, 46(15), 6078–6082.
    CrossRef
  22. Mone N., Nishigandha.; Shital H.; SunitaSalunkeG.; Surekha S.; Archana P.; Vivek M.; Mahesh J.; Ray J. B., Metal complexes of ‘Heena’ (2-hydroxy-1,4-naphthoquinone): Synthesis, Characterization and anticancer activity, , 2023, 546, 121290.
    CrossRef
  23. Ali M.A.; Musthafa SA.; Munuswamy-Ramanujam G.; Jaisankar V.; 3-Formylindole-based chitosan Schiff base polymer: Antioxidant and in vitro cytotoxicity studies on THP-1 cells. Carbohydrate Polymers., 2022, 290, 119501.
    CrossRef
  24. Sreenu D.;Aveli R.; Nirmala G.; Gali R.; Anantha Lakshmi P.V.; Shivaraj., Spectroscopic, quantum chemical calculations, antioxidant, anticancer, antimicrobial, DNA binding and photo physical properties of bioactive Cu(II) complexes obtained from trifluoromethoxy aniline Schiff bases, Journal of Molecular Structure. ,2022, 1249,131601.
    CrossRef
  25. Moamen S. Refat.; Hosam A Saad.; Adil A. Gobouri.; Mohammed Alsawat.; Abdel Majid A. Adam.; Samy M. El-Megharbel., Charge transfer complexation between some transition metal ions with azo Schiff base donor as a smart precursor for synthesis of nano oxides: An adsorption efficiency for treatment of Congo red dye in waste water, Journal of Molecular Liquids., 2022, 345,117140.
    CrossRef
  26. Hasibul Islam, Md.; Md. Abdul Hannan., ‘Schiff Bases: Contemporary Synthesis, Properties, and Applications’. Novelties in Schiff Bases. IntechOpen. 2024, doi:10.5772/intechopen.114850.
    CrossRef
  27. Ramhari M.; Kumari P.; Sharma A.; Fahmi N.; Nighat. Schiff Bases and Their Metal Complexes: Synthesis, Structural Characteristics and Applications.,2023, 5772/intechopen.108396.
  28. Claudel, M., Schwarte, J.V., Fromm, K.M., New Antimicrobial Strategies Based on Metal Complexes. Chemistry. 2020, 2, 849–899.
    CrossRef
  29. Abu-Yamin A.A., Abduh M.S., Saghir S.A.M., Al-Gabri, N., Synthesis, Characterization and Biological Activities of New Schiff Base Compound and Its Lanthanide Complexes. Pharmaceuticals. 2022, 15, 454. https://doi.org/10.3390/ph15040454
    CrossRef
Article Metrics
Views PlumX: 
Views Views:  305 Views
PDF Downloads PDF Downloads:  1170

Article Publishing History
Received on: 24 Sep 2024
Accepted on: 05 May 2025

Article Review Details
Reviewed by: Dr. Munther al-amery
Second Review by: Dr. Naveen Rawat
Final Approval by: Dr. Ioana Stanciu


Share


Journal is Indexed in

Cabells Whitelist


Journal Archived in: